La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Riluzole And NotAssunta Imperato

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000582 Gilbert Bensimon [France] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; Marie Vidailhet [France] ; Christine Payan [France] ; P. Nigel Leigh [Royaume-Uni]Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders : The NNIPPS Study
000F44 Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France]Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice
001032 Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain
001175 A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France]The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation
001221 T. Boraud [France] ; E. Bezard [France] ; J. M. Stutzmann [France] ; B. Bioulac [France] ; C. E. Gross [France]Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
001423 E. Bezard [France] ; J.-M. Stutzmann [France] ; C. Imbert [France] ; T. Boraud [France] ; A. Boireau [France] ; C. E. Gross [France]Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model
001428 A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France]Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole
001641 P. Barneoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubedat [France] ; A. Doble [France] ; A. Boireau [France]Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
001706 ABDELHAMID BENAZZOUZ [France] ; T. Boraud [France] ; P. Dubedat [France] ; A. Boireau [France] ; J.-M. Stutzmann [France] ; C. Gross [France]Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey : a pilot study
001720 A. Boireau [France] ; F. Bordier ; P. Dubedat ; A. DobleMethamphetamine and dopamine neurotoxicity : differential effects of agents interfering with glutamatergic transmission
001786 A. Boireau [France] ; J.-M. Miquet ; P. Dubedat ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo
001787 A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024